Skip Navigation

Study shows male breast cancer patients stop taking tamoxifen early because of drug-related side effects

16 November 2011

The largest study to investigate the tolerability of the breast cancer drug tamoxifen in male breast cancer patients, published in Annals of Oncology, has shown that men stop taking their prescribed therapy early because of problems with side effects caused by the drug.

Read the paper- Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects

Published in Annals of Oncology, Advanced Access, 16th November 2011